Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,055.78
-12.2566-0.59%
Number of Gainers:6
Number of Losers:4
Number of Flat:1
PE:- -
High:2,083.42
Open:2,067.41
Low:2,033.35
Close:2,068.03
Volume:19.22M
Turnover:1.23B
Market Cap:228.45B
Float Cap:227.83B

Loading ...

Belgium's Galapagos 2025 net revenue surges, driven by Gilead collaboration

Reuters
·
37 mins ago

Inovio Shareholders Face April 7 Deadline in Securities Fraud Class Action

Reuters
·
3 hours ago

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
4 hours ago

Arcellx Stock (ACLX) Rockets on a Massive Deal with Gilead Sciences (GILD)

TIPRANKS
·
4 hours ago

Arcellx downgraded to Hold from Buy at Needham

TIPRANKS
·
Yesterday

Arcellx downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB), Integer Holdings (ITGR) and Tonix Pharma (TNXP)

TIPRANKS
·
Yesterday

Gilead Sciences Shares Down 0.8%

THOMSON REUTERS
·
Yesterday

Arcellx downgraded to Equal Weight from Overweight at Wells Fargo

TIPRANKS
·
Yesterday

Aethlon Medical to Present at Emerging Growth Conference

Reuters
·
Yesterday

Top Premarket Gainers

MT Newswires Live
·
Yesterday

Gilead Sciences to Acquire Arcellx in Major Cell-Therapy Deal

TIPRANKS
·
Yesterday

Gilead - IF Deal Is Terminated Under Certain Circumstances, Arcellx to Pay Gilead Termination Fee of $260 Mln

THOMSON REUTERS
·
Yesterday

BRIEF-Gilead Sciences To Acquire Arcellx To Maximize Long-Term Potential Of Anito-Cel

Reuters
·
Yesterday

Deals of the day-Mergers and acquisitions

Reuters
·
Yesterday

Gilead to Acquire Cancer Therapy Developer Arcellx for up to $7.8 Billion

Reuters
·
Yesterday

Gilead to acquire Arcellx for $115 per share in cash at closing, or $7.8B

TIPRANKS
·
Yesterday

Gilead Sciences Shares Down 1.3% Premarket

THOMSON REUTERS
·
Yesterday

Gilead - to Buy Arcellx for $115 per Share in Cash

THOMSON REUTERS
·
Yesterday

Gilead - Deal Expected to Be Accretive to EPS in 2028 and Thereafter

THOMSON REUTERS
·
Yesterday